{
    "title": "Teva hopes Sanofi collaboration will lead to blockbuster IBD drug",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12592267/Teva-hopes-Sanofi-collaboration-lead-blockbuster-IBD-drug.html",
    "date": "2023-10-04",
    "keywords": [
        "drug",
        "teva",
        "sanofi",
        "development",
        "francis",
        "market",
        "growth",
        "phase",
        "scheer",
        "drugmaker",
        "treatment",
        "disease",
        "leader",
        "immunology",
        "launch",
        "asset",
        "hudson",
        "class",
        "product",
        "world",
        "commercialization",
        "jerusalem",
        "bowel",
        "half",
        "executive",
        "richard",
        "case",
        "scenario",
        "colitis",
        "fact",
        "diligence",
        "sanofis",
        "ceo",
        "version",
        "bestinclass",
        "option",
        "collaboration",
        "commitment",
        "need",
        "goal",
        "industry",
        "midday",
        "trade",
        "tel",
        "aviv",
        "paris",
        "loss",
        "exclusivity",
        "copaxone",
        "debt",
        "spate",
        "recovery",
        "trio",
        "ajovy",
        "uzedy",
        "company",
        "bounce",
        "number",
        "pipeline",
        "revenue",
        "outlook",
        "august",
        "ibd",
        "tl1a",
        "driver",
        "partner",
        "deal",
        "payment",
        "cash",
        "transaction",
        "end",
        "share",
        "royalty",
        "arrangement",
        "thirdquarter",
        "europe",
        "israel",
        "america",
        "japan",
        "asia",
        "rest",
        "sharon",
        "singleton",
        "richardson",
        "christina",
        "fincher"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}